Gastric Retentive Drug Delivery system and its recent insights : A Review

Authors

  • Siddhant Rai  Department of Pharmaceutics, IIMT College of Pharmacy, Greater Noida, Uttar Pradesh, India
  • Shaheen Sultana  Department of Pharmaceutics, IIMT College of Pharmacy, Greater Noida, Uttar Pradesh, India

DOI:

https://doi.org/10.32628/IJSRSET2310127

Keywords:

Gastroretentive, Floating system, Mucoadhesive, Alginate, Raft.

Abstract

Oral route is believed to be the most convenient and profoundly accepted drug delivery system and to enhance the efficiency of oral delivery of drug and to overcome the physicochemical and biological barriers in oral delivery, concept of novel delivery system is introduced.Gastro retentive drug delivery system (GRDDS) is one such type of drug delivery system. In conventional delivery system it is hard to provide drug at specific site, but on other hand GRDDS we can retain the drug in stomach for prolong period. There is various approach for retention of drug in stomach like high density, low density (floating system), magnetic, raft forming, bio-adhesive systems, which helps increase the bio-availability of drug. Drugs with good acid solubility, instability at alkaline pH, narrow absorption window, can be formulated by this system. This review includes introduction, potentialcandidates, advantages, disadvantages, approaches, formulation aspects, marketed preparations, current insights including ongoing research and patent works. This review article will help researchers and medical students to have better understanding on GRDDS which ultimately help themin formulation and designing of GRDDS.

References

  1. Bhoyar PK, Baheti JR and Burde VV. An overview of a gastro retentive floating drug delivery system. World Journal of Pharmaceutical research, 1(2): 22-40, (2012)
  2. Lachman L, Liberman HA and Kanig JL. The theory and practice of industrial pharmacy, Lea &Febiger, Philadelphia, 293, ISBN 0-8121-0977-982, (1986)
  3. Streube A, Siepmann J and Bodmeier R. Drug delivery to the upper small intestine window using gastro retentive technologies. Current Opinion in Pharmacology, 6:501–508, (2006)
  4. Das PD, Text book of medicine. Current Book Internationals, 4:182-195, (2000)
  5. Stanley SD. Formulation strategies for absorption windows. Drug Discov Today, 10(4):249-257, (2005)
  6. Khanam N, Alam MI, Sachan AK, et al. Fabrication and evaluation of propranolol hydrochloride loaded microspheres by ionic-gelation technique. Der Pharmacia Lettre, 4(3):815-820, (2012)
  7. Hoffman A. Pharmacodynamic aspects of sustained release preparations. Adv Drug Deliv Rev, 33:185-189, (1998)
  8. Niranjanbhai BD, Mahendrakumar VN, Surendran CS et al. Advances in GRDDS: Raft forming system a review. Journal of Drug Delivery & Therapeutics, 2:123-128, (2012)
  9. Shargel L, Andrew BC, Applied Biopharmaceutics and Pharmacokinetics. London: Prentice Hall Int , 4:112-25, (1999)
  10. Adibkia K, Hamedeyazdan S and Javadzadeh Y. Drug release kinetics and physicochemical characteristics of floating drug delivery systems. Expert Opin Drug Deliv ,8(7):891-903, (2011)
  11. Kaur B, Sharma S, Sharma G, et al. A Review of Floating Drug Delivery System. Asian Journal of Biomedical and Pharmaceutical Sciences, 3(24):1-6, (2013)
  12. Chen YC, Ho H, Lee TY, et al. Physical characterizations and sustained release profiling of gastroretentive drug delivery system with improved floating and swelling capabilities. International Journal Of Pharmaceutics, 44:162-169, (2013)
  13. Kumar R and Philip A. Gastroretentive dosage forms for prolonging gastric residence time. Int J Pharm Med, 21:157–171, (2007)
  14. Sugihara H, Matsui Y, Takeuchi H,. et al. Development of a gastric retentive system as a sustained-release formulation of pranlukast hydrate and its subsequent in vivo verification in human studies. Eur J Pharm Sci, 53:62–68, (2014).
  15. Aoki H, Iwao Y, Mizoguchi M, et al. Clarithromycin highly loaded gastro-floating fine granules prepared by high-shear melt granulation can enhance the efficacy of Helicobacter pylori eradication. Eur J Pharm Biopharm, 92:22–27, (2015)
  16. Arora S, Ali J, Ahuja A, Khar RK and Baboota S. Floating Drug Delivery Systems: A Review. AAPS Pharm. Sci. Tech. 2005; 6 (3): E372-E390.
  17. Singh P, Chaudhari VK, VermaPK, Singh AK and Yadav VK.Multiunit floating drug delivery system a significant tool for the treatment of peptic ulcer disease. International Journal of Pharmaceutical Sciences and Research.2015; 6(4): 1351-1362.
  18. Patil KK and Datta S. A Review on Floating Drug Delivery System. Int. J. Pharm. Sci. Rev. Res. 2013; 21(1): 276-283.
  19. Prajapati, V.D.; Jani, G.K.; Khutliwala, T.A.; Zala, B.S. Raft forming system—An upcoming approach of gastroretentive drug delivery system. J. Control. Release 2013, 168, 151–165.
  20. Mandal, U.K.; Chatterjee, B.; Senjoti, F.G. Gastro‐retentive drug delivery systems and their in vivo success: A recent update. Asian J. Pharm. Sci. 2016, 11, 575–584.
  21. Cvijic, S.; Ibric, S.; Parojcic, J.; Djuris, J. An in vitro—In silico approach for the formulation and characterization of ranitidine gastroretentive delivery systems. J. Drug Deliv. Sci. Technol. 2018, 45, 1–10.
  22. Hooda, A.; Nanda, A.; Jain, M.; Kumar, V.; Rathee, P. Optimization and evaluation of gastroretentive ranitidine HCl microspheres by using design expert software. Int. J. Biol. Macromol. 2012, 51, 691–700.
  23. Odeku, O.; Aderogba, A.; Ajala, T.; Akin‐Anjani, O.; Okunlola, A. Formulation of floating metronidazole microspheres using cassava starch (Manihot esculenta) as polymer. J. Pharm. Investig. 2017, 47, 445–451.
  24. Kagan, L.; Lapidot, N.; Afargan, M.; Kirmayer, D.; Moor, E.; Mardor, Y.; Friedman, M.; Hoffman, A. Gastroretentive Accordion Pill: Enhancement of riboflavin bioavailability in humans. J. Control. Release 2006,113, 208–215.
  25. Qin, C.; Wu, M.; Xu, S.; Wang, X.; Shi, W.; Dong, Y.; Yang, L.; He, W.; Han, X.; Yin, L. Design and optimization of gastro‐floating sustained‐release tablet of pregabalin: In vitro and in vivo evaluation. Int. J.Pharm. 2018, 545, 37–44.
  26. Ngwuluka, N.C.; Choonara, Y.E.; Kumar, P.; du Toit, L.C.; Modi, G.; Pillay, V. An optimized gastroretentive nanosystem for the delivery of levodopa. Int. J. Pharm. 2015, 494, 49–65.
  27. Oh, T.‐O.; Kim, J.‐Y.; Ha, J.‐M.; Chi, S.‐C.; Rhee, Y.‐S.; Park, C.‐W.; Park, E.‐S. Preparation of highly porous gastroretentive metformin tablets using a sublimation method. Eur. J. Pharm. Biopharm. 2013, 83, 460–467.
  28. Singh BN and Kim KH. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J. Control Release, 63:235-259, (2000).
  29. Deshpande AA, Shah NH, Rhodes CT, et al. Controlled Release Drug Delivery Systems for prolonged gastric residence; An overview, Pharm. Res, 22(6):531-539, (1996).
  30. Klausner EA, Lavy E, Friedman M, et al. Novel levodopa gastroretentive dosage form: in-vivo evaluation in dogs. Journal of Controlled Release, 88(1): 117-126, (2003)
  31. Hoffman A and Stepensky D, Pharmacodynamic aspects of modes of drug administration for optimization of drug therapy. Critical Reviews™ in Therapeutic Drug Carrier Systems, 16(6):571-639, (1999).
  32. Smolensky MH and Peppas NA. Chronobiology, drug delivery, and chronotherapeutics. Adv Drug Deliv Rev 59:828-851, (2007).
  33. Roy P and Shahiwala A. Statistical optimization of ranitidine HCl floating pulsatile delivery system for chronotherapy of nocturnal acid breakthrough. Eur J Pharm Sci, 37:363-369, (2009).
  34. Vinod, K., et al., Approaches for gastrotentive drug delivery systems. International Journal of Applied Biology and Pharmaceutical Technology, 2010. 1(2): p. 589-601.
  35. Pawar VK, Kansal S, Asthana S, et al. Industrial Perspective of Gastroretentive Drug Delivery System: Physiochemical, Biopharmaceutical Technological and regulatory considerations. Expert opinion on drug delivery, 9:551-565, (2012)
  36. Badoni A , Ojha A, Gnanarajani G, et al. Review on Gastro Retentive Drug Delivery System. The Pharma Innovation, 1(8): 32-42, (2012)
  37. R. and G. Gupta, Progress in controlled gastroretentive delivery systems. Tropical Journal of Pharmaceutical Research, 2008; 7(3): 1055-1066.
  38. Nayak, A.K., J. Malakar, and K.K. Sen, Gastroretentive drug delivery technologies: Current approaches and future potential. J Pharm Edu Res, 2010; 1(2): 1-12.
  39. Garg, S. and S. Sharma, Gastroretentive drug delivery systems. 2003.
  40. Khosla, R., L. Feely, and S. Davis, Gastrointestinal transit of non-disintegrating tablets in fed subjects. International journal of pharmaceutics, 1989; 53(2): 107-117.
  41. Mojaverian, P., et al., Effects of gender, posture, and age on gastric residence time of an indigestible solid: pharmaceutical considerations. Pharmaceutical research, 1988; 5(10):639-644.
  42. Wilson, C. and N. Washington, The stomach: its role in oral drug delivery. Physiological Pharmaceutical: Biological Barriers to Drug Absorption. Chichester, UK: Ellis Horwood, 1989; 47: 47-70.
  43. Streubel, A., J. Siepmann, and R. Bodmeier, Drug delivery to the upper small intestine window using gastroretentive technologies. Current opinion in pharmacology, 2006; 6(5):501-508.
  44. Devkant S, Anjali S. Gastro retentive drug delivery system. A review. Asian Pac J Health Sci. 2014;1:80-89.
  45. Clarke GM, Newton JM, Short MB. Comparative gastrointestinal transit of pellet systems of varying density. Int J Pharm. 1995;114;1-11.
  46. Streubel A, Siepmann J, Bodmeier R. Gastroretentive drug delivery system. Expert Opin Drug Deliv. 2006;3:217-233.
  47. Thapa P, Jeong SH. Effects of formulation and process variables on gastroretentive floating tablets with a high-dose soluble drug and experimental design approach. Pharmaceutics. 2018;10:161
  48. Patel A, Modasiya M, Shah D, Patel V. Development and in vivo floating behavior of verapamil HCl intragastric floating tablets. AAPS PharmSciTech. 2009;10:310-315.
  49. Zhao Z, Wu C, Zhao Y, Hao Y, Liu Y, Zhao W. Development of an oral push-pull osmotic pump of fenofibrate-loaded mesoporous silica nanoparticles. Int J Nanomedicine. 2015;10:1691-1701. Erratum in: Int J Nanomedicine. 2022;17:15-16.
  50. Saisivam S, Ulla MR, Shakeel F. Development of floating matrix tablet of losartan potassium: in vitro and in vivo evaluation. J Drug Deliv Sci Technol. 2013;23:611-617
  51. Meka L, Kesavan B, Chinnala KM, Vobalaboina V, Yamsani MR. Preparation of a matrix type multiple-unit gastro retentive floating drug delivery system for captopril based on gas formation technique: in vitro evaluation. AAPS PharmSciTech. 2008;9:612-619
  52. Moursy NM, Afifi NN, Ghorab DM, El-Saharty Y. Formulation and evaluation of sustained release floating capsules of nicardipine hydrochloride. Pharmazie. 2003;58:38-43.
  53. Atyabi F, Sharma HL, Mohammad HAH, Fell JT. In vivo evaluation of novel gastric retentive formulation based on ion exchange resin. J Control Release. 1996;42:105-113.
  54. Verma R, Kumar A, Purohit S, Bhandari A. Overview of gastro-retentive drug delivery system. J Natura Conscientia. 2011;2:423-436.
  55. Nayak AK, Malakar J. Formulation and in vitro evaluation of hydrodynamically balanced system for theophylline delivery. J Basic Clin Pharm. 2011;2:133-137
  56. Gupta P, Kumar M, Kaushik D. Pantoprazole sodium loaded microballoons for the systemic approach: in vitro and in vivo evaluation. Adv Pharm Bull. 2017;7:461-467.
  57. Ghareeb MM, Radhi ZA. Formulation and in vitro evaluation of trimetazidine dichloride floating beads. Int J Pharm Sci. 2014;6:456-440.
  58. Kim S, Hwang KM, Park YS, Nguyen TT, Park ES. Preparation and evaluation of non-effervescent gastroretentive tablets containing pregabalin for once-daily administration and dose proportional pharmacokinetics. Int J Pharm. 2018;550:160-169.
  59. Kuldeep V, Sheetal M, Jitendra S, Masheer K. Formulation and evaluation of once a day dual component gastroretentive drug delivery system. Asian J Sci Technol. 2019;10:10247-10254.
  60. Madgulkar A, Kadam S, Pokharkar V. Studies on formulation development of mucoadhesive sustained release itraconazole tablet using response surface methodology. AAPS PharmSciTech. 2008;9:998-1005.
  61. Awasthi  R,  Kulkarni  GT.  Decades  of  research  in  drug  targeting  to the upper gastrointestinal tract using gastroretention technologies:  where  do  we  stand?  Drug  Delivery.  2014  Jul  15;(2):378–94.
  62. Panigrahi KC, Patra ChN, Jena GK, Ghose D, Jena J, Panda SK, et al. Gelucire:  A  versatile  polymer  for  modified  release  drug  delivery system. Future Journal of Pharmaceutical Sciences. 2018;(1):102–8
  63. Kim  S,  Hwang  K-M,  Park  YS,  Nguyen  T-T,  Park  E-S.  Preparation and    evaluation    of    non-effervescent    gastroretentive    tablets containing   pregabalin   for   once-daily   administration   and   dose proportional pharmacokinetics. International Journal of Pharmaceutics. 2018; (1–2):160–9.
  64. Panigrahi KC, Patra ChN, Jena GK, Ghose D, Jena J, Panda SK, et al. Gelucire:  A  versatile  polymer  for  modified  release  drug  delivery system. Future Journal of Pharmaceutical Sciences. 2018;(1):102–8.
  65. Desu P, Paasam V, Kotra V. Formulation and in vitro evaluation of superporous hydrogel based gastroretentive drug delivery system of vildagliptin. J Pharm Res. 2019;23:873-885.
  66. Reddy, L.H.V. and R. Murthy, Floating dosage systems in drug delivery. Critical Reviews™ in Therapeutic Drug Carrier Systems, 2002; 19(6).
  67. Garg, R. and G. Gupta, Progress in controlled gastroretentive delivery systems. Tropical Journal of Pharmaceutical Research, 2008. 7(3): p. 1055-1066.
  68. Dixit, N., Floating drug delivery system. Journal of current pharmaceutical research, 2011. 7(1): p. 6-20.
  69. Kandharkar, S.U., et al., FLOATING DRUG DELIVERY SYSTEM: A REVIEW. PHARMA SCIENCE MONITOR, An International journal pharmaceutical science, 2013. 4(4): p. 3
  70. Kawatra, M., U. Jain, and J. Ramana, Recent advances in floating microspheres as gastro-retentive drug delivery system: A review. International Journal of Recent Advances in Pharmaceutical Research, 2012. 2: p. 5-23.
  71. Sharma, N., et al., A comprehensive review on floating drug delivery system. International Journal of Research in Pharmaceutical and Biomedical Sciences, 2011. 2(2): p. 428-432.
  72. Schneider F, Koziolek M, Weitschies W. In vitro and in vivo test methods for the evaluation of gastroretentive dosage forms. Pharmaceutics. 2019;11:416.
  73. Badoni A, Ojha A, Gnanarajan G, Kothiyal P. Review on gastroretentive drug delivery system. J Pharm Innov. 2012;1:32-42
  74. Malpure PS, Chavan BR, Maru AD, Bhadhane JS, Thakare EB, Sonawane PS. Gastroretentive drug delivery systems. World J Pharm Sci. 2019;8:506-528.
  75. Kumar M, Kaushik D. An Overview on various approaches and recent patents on gastroretentive drug delivery systems. Recent Pat Drug Deliv Formul. 2018;12:84-92.
  76. Tomar A, Upadhyay A, Gupta S, Kumar S. An overview on gastroretentive drug delivery system: current approaches and advancements. Res Pharm Sci. 2019;9:12-16.
  77. Chudiwal V, Shahi S, Chudiwal S, Ahale D. Innovative technologies for gastro-retentive. Asian J Pharm Res 2017;6:22-28. 16. Devkant S, Anjali S. Gastro retentive drug delivery
  78. Vrettos NN, Roberts CJ, Zhu Z. Gastroretentive technologies in tandem with controlled-release strategies: A potent answer to oral drug bioavailability and patient compliance implications. Pharmaceutics. 2021; 13(10):1591.
  79. Schneider F, Koziolek M, Weitschies W. In vitro and in vivo test methods for the evaluation of gastro retentive dosage forms. Pharmaceutics. 2019; 11(8):416.
  80. Pund AU, Shendge RS, Pote AK. Current approaches on gastroretentive drug delivery systems. J Drug Deliv. Ther. 2020;10(1):139- 46.
  81. Bardonnet, P., et al., Gastroretentive dosage forms: Overview and special case of Helicobacter pylori. Journal of controlled release, 2006. 111(1): p. 1-18.
  82. Moya, N., et al., Preparation of floating drug delivery system by plasma technique. Chemical and Pharmaceutical bulletin, The Pharmaceutical society of Japan, 2006. 54(4514)): p. 514-518.
  83. Tripathi, Thapa, Maharjan, & Jeong. (2019). Current State and Future Perspectives on Gastroretentive Drug Delivery Systems. Pharmaceutics, 11(4), 193. doi: 10.3390/pharmaceutics11040193
  84. Khanam, N., Alam, M., Mian, S., & Srinivas, N. (2017). A REVIEW ON NOVEL APPROACHES INCORPORATED IN THE FORMULATION OF GASTRO RETENTIVE DRUG DELIVERY SYSTEM. International Journal Of Pharmacy And Biological Sciences, 7(1), 52-60. doi: 10.21276/ijpbs.2017.7.1.7
  85. Rabia Aslam, Yasir Mehmood, Sidra Khan, Hammad Yousaf, TECHNIQUES AND POLYMERS USED TO DESIGN GASTRORETENTIVE DRUG DELIVERY SYSTEMS – A REVIEW, WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, Volume 3, Issue 12, 97-110.
  86. Ayesha Tariq, Irfan Bashir, Khalid Idrees Khan, Imtiaz Majeed1, Nadiah Zafar, Imran Sajid, STRUCTURAL COMPONENTS OF GASTRO-RETENTIVE DRUG DELIVERY SYSTEMS, Indo American Journal of Pharmaceutical Research, pg 3866.
  87. Jaimini M, Rana AC, Tanwar YS. Formulation and evaluation of famotidine floating tablet. Curr Drug Deliv, 2007; 4(1): 51-55.
  88. Mandal UK, Chatterjee B and Faria Gias Senjoti FG. Gastro-retentive drug delivery systems and their in vivo success: A recent update. asian journal of pharmaceutical sciences, 11:575–584, (2016)
  89. https://patents.google.com/?q=Grdds+patents&oq=Grdds+patents

International Journal of Scientific Research in Science, Engineering and Technology

Downloads

Published

2023-02-28

Issue

Volume 10, Issue 1, January-February-2023

Section

Research Articles

License

Copyright (c) IJSRSET

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

[1]
Siddhant Rai, Shaheen Sultana "Gastric Retentive Drug Delivery system and its recent insights : A Review" International Journal of Scientific Research in Science, Engineering and Technology (IJSRSET), Print ISSN : 2395-1990, Online ISSN : 2394-4099, Volume 10, Issue 1, pp.264-281, January-February-2023. Available at doi : https://doi.org/10.32628/IJSRSET2310127